- An interferon-free regimen of simeprevir (SMV; Olysio), daclatasvir (DCV; Daklinza), and ribavirin (RBV) achieved a 91% HCV-1b clearance rate in liver transplant (LT) recipients.
- Coadministration of cyclosporine (CsA) is not recommended.
Why this matters
You’ve reached the visitor articles limit
reserved for healthcare professionals
Register to read more
Already have an account? Login now